• +1 700 888 1234

  • Effingerstrasse 40 3008 Bern Switzerland

LuCE presents country reports based on 2023 research on financial toxicity

We are pleased to announce the launch of nine Lung Cancer Europe (LuCE) country reports based on the data from […]

LuCE seeks to fill key roles

Join our team at Lung Cancer Europe (LuCE) and become part of a dedicated group of individuals who are driven […]

FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer

Some positive news last week when the U.S. Food and Drug Administration (FDA) approved alectinib as an adjuvant treatment for […]